Kevin Perron is a corporate associate in the Boston office of Kirkland & Ellis LLP. Kevin’s practice focuses on mergers and acquisitions involving public and private companies. Kevin also has experience with financing and restructuring matters.
Experience
Representative Matters
Prior to joining Kirkland, Kevin was involved in the following representative matters:
Vertex Pharmaceuticals in its $4.9 billion acquisition of Alpine Immune Sciences
Ambrx Biopharma in its $2 billion acquisition by Johnson & Johnson
Mirati Therapeutics in its sale to Bristol Myers Squibb for up to $5.8 billion
Apria in its $1.45 billion acquisition by Owens & Minor
CorePoint Lodging in its $1.5 billion acquisition by a joint venture between affiliates of Highgate and Cerberus Capital Management
Hilton Grand Vacations in connection with the financing for its acquisition of Diamond Resorts for $1.4 billion
EQT in connection with the financing for its acquisition of First Student and First Transit for $4.6 billion
Clerk & Government Experience
Judicial ClerkHonorable Judge Thomas L. AmbroUnited States Court of Appeals for the Third Circuit2022–2023
Prior Experience
Skadden, Arps, Slate, Meagher & Flom LLP
Simpson Thacher & Bartlett LLP
More
Credentials
Admissions & Qualifications
2023Massachusetts
2021New York
Education
Columbia Law SchoolJ.D.2020
James Kent Scholar
Bowdoin CollegeB.A., Government and Legal Studies & English2016
